EU seeks Moderna COVID vaccine deal at below $25 per dose-source
Moderna said on Monday its experimental vaccine was 94.5% effective in preventing COVID-19, based on interim data from a late-stage clinical trial.
Moderna said on Monday its experimental vaccine was 94.5% effective in preventing COVID-19, based on interim data from a late-stage clinical trial. The EU has been in talks with Moderna for its experimental COVID-19 vaccine at least since July, an internal EU document seen by Reuters shows.
The Economic Times Business News App for the Latest News in Business, Sensex, Stock Market Updates & More.
The Economic Times News App for Quarterly Results, Latest News in ITR, Business, Share Market, Live Sensex News & More.